A pioneer study unveiled a decisive role for unliganded PR in breast cancer cells by targeting a multiprotein complex to locally close chromatin and regulate basal transcription of PR-responsive genes, probably to avoid any aberrant activation in the absence of ligand [13]. The gene discussed is PGR; the disease is breast carcinoma.